End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.688 EUR | -4.44% | -18.48% | -76.28% |
15/05 | Acticor: 'new perspectives' in stroke treatment | CF |
15/05 | Acticor Biotech Announces Presentation of the Main Results of the Phase 2/3 Actisave Study in the Treatment of Stroke at ESOC 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
98L | - | - | - | - | - | |
12TCr | ||||||
11TCr | ||||||
2.43TCr | - | |||||
2.2TCr | - | |||||
1.82TCr |